Ace Therapeutics makes it easy to make non-invasive, label-free and real-time recordings from your cell network with microelectrode array (MEA). In addition, our MEA electrophysiology of electrically active cells such as neurons can help researchers uncover psychiatric disorders and drug interactions.
Electrical recording of neuronal activity has been the method of choice for the analysis of individual neurons and neuronal networks. Electrodes placed in vitro within brain slices or inserted in vivo into the brain detect electrical signals generated by surrounding cells. MEA has been widely used to measure neuronal activity in vitro as a non-invasive, long-term, multi-cellular method with the key advantage of being able to record and stimulate neurons at multiple sites simultaneously. MEA can be used to understand neuronal communication, information encoding, propagation, processing and neuronal circuit computation.
Fig. 1 Spontaneous firing in cortical neurons in vitro, as revealed by MEA. (Lu C, et al., 2016)
Ace Therapeutics makes it easy to make non-invasive, label-free and real-time recordings from your cell network with MEA technology. We offer high-density MEA-based technology that allows the study of physiological and pathological functional activities in different models, such as cell culture (primary or stem cell-derived), brain sections (acute or organotypic), retina or brain-like organs. Especially in brain slices, MEA allows recording spike activity and field potential propagation in different regions with unprecedented spatial and temporal resolution.
Ace Therapeutics is committed to providing versatile tools for the detailed study of neuronal signaling mechanisms and to improving the quality and reliability of antipsychotic drug screening or toxicology assays. We aim to provide advanced MEA technology to help you achieve faster data analysis and accurate measurements and to advance your understanding of the pathogenesis of psychiatric disorders. If you are interested in MEA services, please feel free to
.Enter your E-mail and receive the latest news from us